A randomised trial of non-mydriatic ultra-wide field retinal imaging versus usual care to screen for diabetic eye disease: rationale and protocol for the Clearsight trial

INTRODUCTION: Suboptimal screening for diabetic eye disease is a major cause of preventable vision loss. Screening barriers include mydriasis and the extra time patients need to attend dedicated eye screening appointments. In the Clearsight trial, we are testing whether screening by non-mydriatic ul...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMJ Open
Main Authors: Liu, Selina L, Mahon, Lewis W, Klar, Neil S, Schulz, David C, Gonder, John R, Hramiak, Irene M, Mahon, Jeffrey L
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2017
Teme:
Diabetes and Endocrinology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5724207/
https://ncbi.nlm.nih.gov/pubmed/28775182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015382
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki